Role of reactive oxygen species in occupational and environmental obstructive pulmonary diseases

Current Opinion in Pulmonary Medicine

Volumn 5, Issue 2, 1999, Pages 118-123

  Van Klaveren, Rob J ^a   Nemery, Benoit ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MINERAL; REACTIVE OXYGEN METABOLITE;

AIR POLLUTANT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DUST; ENVIRONMENTAL DISEASE; HUMAN; OCCUPATIONAL DISEASE; REVIEW; SMOKE;

AIR POLLUTANTS; DUST; ENVIRONMENTAL ILLNESS; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MINERALS; OCCUPATIONAL DISEASES; REACTIVE OXYGEN SPECIES; SMOKE;

EID: 0033085687     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199903000-00007     Document Type: Article

References (55)

1. van Klaveren RJ, Demedts M, Nemery B: Cellular glutathione turnover in vitro with emphasis on type II pneumocytes. Eur Respir J 1997, 10:1392-1400.
2. Rahman I, Morrison D, Donaldson K, MacNee W: Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996, 154:1055-1060.
3. Heffner JA, Repine JE: State of the art: pulmonary strategies of antioxidant defence. Am Rev Respir Dis 1989, 140:531-554.
4. Halliwell B: Antioxidants in human health and disease. Annu Rev Nutr 1996, 16:33-50.
5. Bast A, Haenen GRMM, Doeleman CJA: Oxidants and antioxidants: state of the art. Am J Med 1991, 91:2-13.
6. Repine JE, Bast A, Lankhorst I, the Oxidative Stress Study Group: Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997, 156:341-357. In this State of the Art, more than 200 papers about the role of oxidative stress in COPD are reviewed. This can be considered as a reference paper. From this review it becomes obvious that the balance between oxidants and antioxidants is disturbed in smokers. It remains unclear, however, why only certain subjects develop COPD.
7. Pryor WA: Biological effects of cigarette smoke, wood smoke, and the smoke from plastics: the use of electron spin resonance. Free Radic Biol Med 1992, 13:659-676.
8. Morrison D, Lannan S, Langridge A, Rahman I, MacNee W: Effect of acute cigarette smoking on epithelial permeability, inflammation and oxidant status in the airspaces of chronic smokers. Thorax 1994, 49:1077-1084.
9. Rahman I, MacNee W: Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996, 51:348-353.
10. Bui MH, Sauty A, Collet F, Leuenberger P: Dietary vitamin C intake and concentrations in the body fluids of cells of male smokers and non-smokers. J Nutr 1992, 122:312-336.
11. Pacht ER, Kaseki H, Mohammed JR, Comwell DG, Davis WR: Deficiency of vitamin E in the alveolar fluid of cigarette smokers: influence on alveolar macrophages cytotoxicity. J Clin Invest 1988, 77:789-796.
12. 2-isoprostanes) in smokers. N Engl J Med 1995, 332:1198-1203.
13. Dekhuijzen PNR, Aben KKH, Dekker I, Aarts LPHJ, Wielders PLML, van Herwaarden CLA, Bast A: Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 154:813-816.
14. Bascom R: Health effects of outdoor air pollution. Am J Respir Crit Care Med 1996, 153:43-50.
15. Weinmann GG, Bowes SM, Gerbase MW, Kimball AW, Frank R: Response to acute ozone exposure in healthy men: results of a screening procedure. Am J Respir Crit Care Med 1995, 151:33-40.
16. Weinmann GG: An update on air pollution. Curr Opin Pulm Med 1996, 2:121-128.
17. Frampton MW, Morrow PE, Torres A, Cox C, Voter KZ, Utell MJ: Ozone responsiveness in smokers and non-smokers. Am J Respir Crit Care Med 1997, 155:116-121. Healthy smokers have smaller decrements in lung function and fewer symptoms in response to ozone than do nonsmokers. As a possible explanation, the authors suggest that the airways of smokers might be less responsive to irritants in general, or that ozone might reduce the ozone responsiveness.
18. Torres A, Utell MJ, Morow PE, Voter KZ, Whitin JC, Cox C, et al.: Airway inflammation in smokers and non-smokers with varying responsiveness to ozone. Am J Respir Crit Care Med 1997, 156:728-736. The conclusion of this study is that ozone-induced airway inflammation is independent of smoking status or airway responsiveness to ozone, which means that both smokers and nonsmokers may experience airway inflammation even in the absence of symptoms or changes in lung function.
19. Kleeberger SR: Genetic susceptibility to ozone exposure. Toxicol Lett 1995, 82/83:295-300.
20. Kleeberger SR, Levitt RC, Zhang LY: Susceptibility to ozone-induced inflammation: I. Genetic control of the response to subacute exposure. Am J Physiol 1993, 264:L15-L20.
21. Prows DR, Shertzer HG, Caly MJ, Sidman CL, Leikauf GD: Genetic analysis of ozone-induced acute lung injury in sensitive and resistant trains of mice. Nat Genet 1997, 17:471-474. These findings suggest the implication of various genetic and epigenetic factors in individual susceptibility to air pollution.
22. Kleeberger SR, Levitt RC, Zhang L, Longphre M, Harkema J, Jedlicka A, et al.: Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice. Nat Genet 1997, 17;475-478.
23. Balmes JR, Chen LL, Scannell C, Tager I, Christian D, Hearne PQ, et al.: Ozone-induced decrements in FEV1 and FVC do not correlate with measures of inflammation. Am J Respir Crit Care Med 1996, 153:904-909.
24. Christian DL, Chen LL, Scannell CH, Ferrando RE, Welch BS, Balmes JR: Ozone-induced inflammation is attenuated with multiday exposure. Am J Respir Crit Care Med 1998, 158:532-537. This study suggests that there is attenuation of the ozone-induced airway inflammation in both the proximal and distal airways upon repeated daily exposures. Although neutrophil recruitment is attenuated, airway injury may continue to occur.
25. McKinney WJ, Jaskot RH, Richards JH, Costa DL, Dreher KL: Cytokine mediation of ozone-induced pulmonary adaptation. Am J Respir Cell Mol Biol 1998, 18:696-705. This study demonstrates that antioxidants are not involved in the early adaptive response to ozone, but that interleukin-6 is an essential mediator of this adaptation.
26. Vargas MH, Romero L, Sommer B, ZamudioP, Gustin P, Montano LM: Chronic exposure to ozone causes tolerance to airway hyperresponsiveness in guinea pigs: lack of SOD role. J Appl Physiol 1998, 84:1749-1755. Although superoxide anion has been found to be implicated in the acute effects of ozone, SOD does not play a role in the tolerance phenomenon to ozone.
27. Weller BL, Crapo JD, Slot J, Posthuma G, Plopper CG, Pinkerton KE: Site-and cell-specific alterations of lung copper/zinc and manganese superoxide dismutase by chronic ozone exposure. Am J Respir Cell Mol Biol 1997, 17:552-560. In this study the heterogeneous response of the epithelial cells within the airways and lung parenchyma to ozone is illustrated. Although no induction was noted in type I epithelial cells, fibroblasts, and Clara cells, type II epithelial cells increased their manganese SOD and showed resistance against repeated ozone exposure.
28. Mudway IS, Kelly FJ: Modeling the interactions of ozone with pulmonary epithelial lining fluid antioxidants. Toxicol Appl Pharmacol 1998, 148:91-100. In this study the relative reactivity of ozone with the antioxidants in the epithelial lining fluid is investigated. Uric acid appeared to be the most important protective antioxidant against ozone toxicity.
29. Postlethwait EM, Cueto R, Velsor LW, Pryor WA: Ozone-induced formation of bioactive lipids: estimated surface concentrations and lining layer effects. Am J Physiol (Lung Cell Mol Physiol 18) 1998, 274:L1006-L1016. This study suggests that ozone does not react directly with the epithelium. Ozone reacts with unsaturated fatty acids and produces bioactive lipid oxidation products, which might be responsible for the toxic effects of ozone.
30. Hatch G, Slade R, Harris L, McDonnell W, Devlin R, Koren H, Costa D, McKee J: Ozone dose and effect in humans and rats. Am J Respir Crit Care Med 1994, 150:676-683.
31. Weinmann G, Weidenbach-Gerbase M, Foster W, Zacur H, Frank R: Evidence for ozone-induced small airway dysfunction: lack of menstrual-cycle and gender effects. Am J Respir Crit Care Med 1995, 152:988-996.
32. Romieu I, Meneses F, Ramirez M, Ruiz M, Ruiz S, Padilla RP, et al.: Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone. Am J Respir Crit Care Med 1998, 158:226-232. This study demonstrates that supplementation with a cocktail of antioxidants is useful in the protection against the decremental effects of ozone on lung function even in a population who was not deficient in vitamin E and only slightly deficient in β-carotene.
33. Grievink L, Jansen SMA, van t' Veer P, Brunekreef B: Acute effects of ozone on pulmonary function of cyclists receiving supplements. Occup Environ Med 1998, 55:13-17.
34. Grievink L, Zijlstra AG, Ke X, Brunekreef B: Acute effects of ozone on pulmonary function in antioxidant supplemented cyclists [abstract]. Eur Respir J 1997, 10(suppl 25):299S.
35. Schwartz J: Air pollution and daily mortality: a review and meta-analysis. Environ Res 1994, 64:36-52.
36. Pope CA, Dockery DW, Schwartz J: Review of epidemiological evidence of health effects of particulate air pollution. Inhalation Toxicol 1995, 7:1-18.
37. Dockery DW, Pope CA: Acute respiratory effects of particulate air pollution. Annu Rev Public Health 1994, 15:107-132.
38. 10 was associated with decreased forced expiratory volume in 1 second percent predicted in nonsmoking men with a parental history of respiratory disease, with a decreased forced expiratory volume in 1 second/vital capacity in men who had never smoked and with an increased PEF variability in women and men who had never smoked.
39. Menzel DB: The toxicity of air pollution in experimental animals and humans: the role of oxidative stress. Toxicol Lett 1994, 72:269-277.
40. Vallyathan A, Shi X: The role of oxygen free radicals in occupational and environmental lung diseases. Environ Health Perspect 1997, 105:165-171. This paper reviews the role of ROS in occupational and environmental lung diseases.
41. Dreher K, Jaskot R, Kodavanti U, Lehmann J, Winsett D, Costa D: Soluble transition metals mediate the acute pulmonary injury and airway hyperreactivity induced by residual oil fly ash particles. Chest 1996(suppl 3), 109:33S-34S.
42. Pritchard RJ, Ghio AJ, Lehman JR, Winsett DW, Tepper JS, Park P, et al.: Oxidant generation and lung injury after particulate air pollutant exposure increase with the concentration of associated metals. Inhal Toxicol 1996, 8:457-477.
43. Dreher KL, Jaskot RH, Lehmann JR, Richards JH, McGee JK, Ghio AJ, Costa DL: Soluble transition metals mediate residual oil fly ash induced acute lung injury. J Toxicol Environ Health 1997, 50:285-305.
44. Dye JA, Adler KB, Richards JH, Dreher KL: Epithelial injury induced by exposure to residual oil fly-ash particles: role of reactive oxygen species? Am J Respir Cell Mol Biol 1997, 17:625-633.
45. Carter JD, Ghio AJ, Samet JM, Devlin RB: Cytokine production by human airway epithelial cells after exposure to an air pollution particle is metal-dependent. Toxicol Appl Pharmacol 1997, 146:180-188. This study demonstrates that metals present in ROFA are responsible for production and release of inflammatory mediators by the respiratory tract epithelium.
46. Quay JL, Reed W, Samet J, Devlin RB: Air pollution particles induce IL-6 gene expression in human airway epithelial cells via NF-kB activation. Am J Respir Cell Mol Biol 1998, 19:98-106. In this study ROFA has been found to activate NF-KB as a first step in the inflammatory cascade.
47. Zhang Q, Kusaka Y, Sato K: Differences in the extent of inflammation caused by intratracheal exposure to three ultrafine metals: role of free radicals. J Toxicol Environ Health 1998, 53:423-438. In this study, the role of ultrafine particles less than 20 nm in diameter in the pathogenesis of airway inflammation is discussed.
48. Donaldson K, Beswick PH, Gilmour PS: Free radical activity associated with the surface of particles: a unifying factor in determining biological activity. Toxicol Lett 1996, 88:293-298.
49. Churg A, Brauer M, Keeling B: Ozone enhances the uptake of mineral particles by tracheobronchial epithelial cells in organ culture. Am J Respir Crit Care Med 1996, 153:1230-1233.
50. Ghio AJ, Carter JD, Samet JM, Reed W, Quay J, Dailey LA, Richards JH: Metal-dependent expression of ferritin and lactoferrin by respiratory epithelial cells. Am J Physiol (Lung Cell Mol Physiol 18) 1998, 274:L728-L736.
51. Oxman AD, Muir DCF, Shannon HS, Stock SR, Hnizdo E, Lange HJ: Occupational dust exposure and chronic obstructive pulmonary disease: systemic overview of the evidence. Am Rev Respir Dis 1993, 148:38-48.
52. Vallyathan V, Mega JF, Shi X, Dalal NS: Enhanced generation of free radicals from phagocytes induced by mineral dusts. Am J Respir Cell Mol Biol 1992, 6:404-413.
53. Schapira RM, Ghio AJ, Effros RM, Morrisey J, Almangro UA, Dawson CA, Hacker AD: Hydroxyl radical production and lung injury in the rat following silica or titanium dioxide instillation in vivo. Am J Respir Cell Mol Biol 1995, 12:220-226.
54. Schapira RM, Ghio AJ, Effros RM, Morrisey J, Dawson CA, Hacker AD: Hydroxyl radicals are formed in rat lung after asbestos instillation in vivo. Am J Respir Cell Mol Biol 1994, 10:573-579.
55. Shi X, Dalal NS, Vallyathan V: ERS evidence for the hydroxyl radical formation in aqueous suspension of quartz particles and its possible significance to lipid peroxidation in silicosis. J Toxicol Environ Health 1988, 25:235-245.